A detailed history of Gtcr LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Gtcr LLC holds 20,150,005 shares of MRVI stock, worth $113 Million. This represents 13.05% of its overall portfolio holdings.

Number of Shares
20,150,005
Holding current value
$113 Million
% of portfolio
13.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $138 Million - $196 Million
20,150,005 New
20,150,005 $167 Billion
Q2 2024

Aug 09, 2024

SELL
$6.87 - $11.34 $10.5 Million - $17.4 Million
-1,531,028 Reduced 7.06%
20,150,005 $144 Million
Q3 2021

Nov 01, 2021

SELL
$36.8 - $60.62 $108 Million - $178 Million
-2,931,441 Reduced 11.91%
21,681,033 $1.06 Billion
Q2 2021

Aug 05, 2021

SELL
$32.46 - $45.0 $98.5 Million - $137 Million
-3,034,041 Reduced 10.97%
24,612,474 $1.03 Billion
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $677 Million - $853 Million
27,646,515 New
27,646,515 $775 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $741M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Gtcr LLC Portfolio

Follow Gtcr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gtcr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gtcr LLC with notifications on news.